Licella has acquired 1 company, including 1 in the last 5 years.
The Company’s most targeted sectors include life science (100%).
Level 7, 140 Arthur St,
North Sydney,
NSW 2060
Australia,
+61 (02) 9119 6050
www.licella.com.au
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2020-10-14 |
Arbios Biotech · Life Science
, Australia · www.arbiosbiotech.com Arbios Biotech is a joint venture between technology pioneers Licella and integrated forest products company Canfor. Arbios Biotech uses cutting-edge technology to convert end-of-life wood and biomass into renewable biofuels and biochemicals. It collaboratively provides a circular economy solution for recovered resources, to enable the production of high-value and sustainable carbon-based products. |
- | Joint Venture | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
